Periconceptional Folic Acid Supplementation and Infant Risk of Congenital Heart Defects inNorway 1999–2009
Open Access
- 24 July 2015
- journal article
- Published by Wiley in Paediatric and Perinatal Epidemiology
- Vol. 29 (5) , 391-400
Abstract
Background: The birth prevalence of congenital heart defects (CHDs) has decreased inCanada and Europe. Recommended intake of folic acid in pregnancy is a suggestive risk‐reducing factor forCHDs. We investigated the association between periconceptional intake of folic acid supplements and infant risk ofCHDs.Methods: Information on maternal intake of folic acid supplements before and during pregnancy in the Medical Birth Registry ofNorway 1999–2009 was updated with information onCHDdiagnoses from national health registers and the Cardiovascular Diseases inNorway Project. The association between folic acid intake and infant risk ofCHDwas estimated as relative risk (RR) with binomial log linear regression.Results: Among 517 784 non‐chromosomal singleton births, 6200 children were identified withCHDand 1153 with severeCHD. For all births, 18.4% of the mothers initiated folic acid supplements before pregnancy and 31.6% during pregnancy. The adjustedRRfor severeCHDwas 0.99 [95% confidence interval [CI] 0.86, 1.13] comparing periconceptional intake of folic acid with no intake. Specifically,RRfor conotruncal defects was 0.99 [95%CI0.80, 1.22], atrioventricular septal defects 1.19 [95%CI0.78, 1.81], left ventricular outflow tract obstructions 1.02 [95%CI0.78, 1.32], and right ventricular outflow tract obstructions 0.97 [95%CI0.72, 1.29]. Birth prevalence of septal defects was higher in the group exposed to folic acid supplements withRR1.19 [95%CI1.10, 1.30].Conclusions: Periconceptional folic acid supplement use showed no association with severe CHDs in the newborn. An unexpected association with an increased risk of septal defects warrants further investigation.Keywords
Funding Information
- Norges Forskningsråd (190858/V50)
This publication has 24 references indexed in Scilit:
- Recent Decrease in the Prevalence of Congenital Heart Defects in EuropeThe Journal of Pediatrics, 2013
- Protective effect of periconceptional folic acid supplements on the risk of congenital heart defects: a registry-based case-control study in the northern NetherlandsEuropean Heart Journal, 2009
- Prevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, CanadaBMJ, 2009
- National time trends in congenital heart defects, Denmark, 1977-2005American Heart Journal, 2009
- Seeking causes: Classifying and evaluating congenital heart defects in etiologic studiesBirth Defects Research Part A: Clinical and Molecular Teratology, 2007
- Trends of selected malformations in relation to folic acid recommendations and fortification: An international assessmentBirth Defects Research Part A: Clinical and Molecular Teratology, 2006
- Changes in knowledge and attitudes of folate, and use of dietary supplements among women of reproductive age in Norway 1998 - 2000Scandinavian Journal of Public Health, 2004
- The Medical Birth Registry of Norway. Epidemiological research and surveillance throughout 30 yearsActa Obstetricia et Gynecologica Scandinavica, 2000
- Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin SupplementationNew England Journal of Medicine, 1992
- Multivitamin/Folic Acid Supplementation in Early Pregnancy Reduces the Prevalence of Neural Tube DefectsJAMA, 1989